- Transient Receptor Potential Canonical 5 (TRPC5) is protective in chronic arthritis induced by Complete Freund’s Adjuvant (CFA)
KM Alawi, FA Russell, AA Aubdool, P Thakore, ES Fernandes, SD Brain
- Transient Receptor Potential Melastatin 8 (TRPM8) interacts with co-expressed Transient Receptor Potential Vanilloid 1 (TRPV1) and Ankyrin 1 (TRPA1).
Sadofsky L, Crow C, Hayman Y, Morice A
- TRANSIENT RECEPTOR POTENTIAL VANILLOID SUBTYPE 1 (TRPV1) IN ALZHEIMER DISEASE AND THE EFFECTS OF CANNABINOIDS
Aguirre Rueda D, Valles S
- Translational pharmacokinetic-pharmacodynamic analysis of sedative effects in rats and humans using published data
K. Tse1, P. Nordell2, M. Rolf2, W. S. Redfern1. 1Drug Safety and Metabolism, AstraZeneca, Cambridge, United Kingdom, 2Drug Safety and Metabolism, AstraZeneca, M”lndal, Sweden
- Translational pharmacology of selected compounds at the human and canine α1a adrenergic receptors
S. Cummings, R. McCoy, S. Robson, J. Beltra & G. McMurray
- Translational studies of vasopressin in rat, ferret, shrew and human gastric antrum.
Broad J, Percie du Sert N, Andrews P, Sanger G
- Translational study of auditory event related potentials as a potential central nervous system biomarkers with lorazepam
A. McCarthy, C. Brittain, S. Lowe, K. Wafford. Eli Lilly and Company, Windlesham, United Kingdom
- Translational understanding of the cardiovascular risk due to alpha2A-adrenoceptor antagonism
L. Roberts1, C. W. Scott2, A. Harmer1. 1Discovery Safety, AstraZeneca, Cambridge, United Kingdom, 2Discovery Safety, AstraZeneca, Waltham,
- Translation of species differences in histamine H4 pharmacology with PF-2988403
Clarke Nicholas, Brown Chris, Lane Charlotte, Mowbray Charlie, Lim Herman, Leurs Rob, Schenck Emanuel, Perros-Huguet Christelle, Yeadon Mike
- Transporter interaction of warfarin, a traditional oral vitamin K antagonist with the mouse blood-brain barrier in vitro: evidence for BCRP involvement.
H Wang, P Muresan, G Sekhar, R Brown, J Patel, R Arya, S Jones, S Thomas
